Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Acta Pharmaceutica Sinica. B
|
March 27, 2023
The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis <i>via</i> blocking inactive rhomboid protein 2-dependent pathway
Minxuan Xu, Jun Tan, Liancai Zhu, et al.
The Journal of Nutritional Biochemistry
|
December 14, 2019
Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling
Lin-Feng Hu, Jing Feng, Xianling Dai, et al.
Redox Biology
|
September 1, 2020
Nrf2 mitigates prolonged PM2.5 exposure-triggered liver inflammation by positively regulating SIKE activity: Protection by Juglanin
Chenxu Ge, Jun Tan, Shaoyu Zhong, et al.
Nature Communications
|
February 26, 2022
The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes
Minxuan Xu, Jun Tan, Wei Dong, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Acta Pharmaceutica Sinica. B
|
March 27, 2023
The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis <i>via</i> blocking inactive rhomboid protein 2-dependent pathway
Minxuan Xu, Jun Tan, Liancai Zhu, et al.
The Journal of Nutritional Biochemistry
|
December 14, 2019
Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling
Lin-Feng Hu, Jing Feng, Xianling Dai, et al.
Redox Biology
|
September 1, 2020
Nrf2 mitigates prolonged PM2.5 exposure-triggered liver inflammation by positively regulating SIKE activity: Protection by Juglanin
Chenxu Ge, Jun Tan, Shaoyu Zhong, et al.
Nature Communications
|
February 26, 2022
The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes
Minxuan Xu, Jun Tan, Wei Dong, et al.
Page
of 2